Assessing mortality trends among patients with lip and oral cavity cancer due to tobacco consumption: A systematic analysis of the Global Burden of Disease-2021.

M Mishaim Khan (FMH College of Medicine & Dentistry, Lahore, Pakistan) S Shree Rath (All India Institute of Medical Sc., Bhubaneswar, India) O Osama Ahmad (Khyber Medical College, Peshawar, Pakistan) M Muzamil Khan (The George Washington University, Washington, District of Columbia, United States) N Nouman Aziz (6Wyckoff Heights Medical Center, Brooklyn, United States) W Waseem Nabi (5University Florida, Gainsville, United States)

Abstract

e18134 Background: Tobacco is an established risk factor for lip and oral cavity cancer (LOC). While a previous study quantified the global and regional burden of LOC and other pharyngeal cancers using the 2019 Global Burden of Diseases, Injuries, and Risk Factors (GBD) study estimates, comprehensive and up-to-date evaluations of tobacco-attributable LOC burden across different locations remain lacking. Given that LOC is an important contributor to the global cancer burden, this study aims to provide a thorough evaluation of the tobacco-attributed global and regional burden of LOC to enhance effective policy planning. Methods: In this analysis of GBD 2021 data, we examined temporal trends in mortality, years lived with disability (YLD), years of life lost (YLL), and disability-adjusted life-years (DALY) globally and in 204 countries and territories from 1990 to 2021 using age-adjusted standardized rates across all ages and sexes. Temporal trends were assessed using the average annual percentage change (AAPC) and corresponding 95% confidence intervals (CI). Metrics were calculated using standardized GBD methods, and the findings were stratified by country, with a comprehensive global summary highlighting the overarching pattern. Results: Globally, the burden of lip and oral cancers caused by tobacco has increased across all metrics from 1990 to 2021. The global AAPC was 0.38 (95%CI 0.38-0.45, p<0.001) for death, 1.02 (95%CI 0.93-1.11, p<0.001) for YLD, 0.28 (95%CI 0.21-0.34, p<0.001) for YLL and 0.29 (95%CI 0.23-0.35, p<0.001) for DALY. Regionally, Cabo Verde experienced the highest increases across all metrics, with AAPC values of 8.45 (95%CI 5.8-11.1) for mortality, 8.99 (95%CI 6.4-11.5) for YLD, 8.10 (95%CI 5.4-10.7) for YLL and 8.12 (95%CI 5.4-10.8) for DALY indicating a concerning rise in disease burden. Conversely, Canada showed the largest declines, with AAPC values of -2.78 (95%CI -2.9 to -2.5) for mortality, -2.06 (95%CI -2.1 to -1.9) for YLD, -2.95 (95%CI -3.1 to -2.7) for YLL and -2.89 (95%CI -3.0 to -2.7) for DALY reflecting notable improvements, likely attributed to effective tobacco control efforts. Conclusions: The global burden of LOC caused by tobacco remains substantial with marked regional disparities. Cabo Verde has emerged as a region requiring urgent targeted interventions, while Canada’s declining trends highlight the effectiveness of comprehensive tobacco control strategies. These findings enhance our understanding of the distribution and disparities in the LOC burden and underscore the need for synergistic, systematic, and multi-sectoral efforts, modeled after Canada, to mitigate this burden.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

M

Mishaim Khan

FMH College of Medicine & Dentistry, Lahore, Pakistan

S

Shree Rath

All India Institute of Medical Sc., Bhubaneswar, India

O

Osama Ahmad

Khyber Medical College, Peshawar, Pakistan

M

Muzamil Khan

The George Washington University, Washington, District of Columbia, United States

N

Nouman Aziz

6Wyckoff Heights Medical Center, Brooklyn, United States

W

Waseem Nabi

5University Florida, Gainsville, United States